87835-103 NDC - BIO COMBINATION 28 (SCHUESSLER SALTS)

Drug Information

  • Product NDC: 87835-103
  • Proprietary Name: Bio Combination 28
  • Non Proprietary Name: Schuessler Salts
  • Active Ingredient(s): 37.5 g/450g CALCIUM FLUORIDE; 37.5 g/450g CALCIUM PHOSPHATE; 37.5 g/450g FERROUS PHOSPHATE; 37.5 g/450g POTASSIUM CHLORIDE; 37.5 g/450g POTASSIUM SULFATE; 37.5 g/450g MAGNESIUM PHOSPHATE; 37.5 g/450g SODIUM CHLORIDE; 37.5 g/450g SODIUM PHOSPHATE; 37.5 g/450g SODIUM SULFATE; 37.5 g/450g SILICON DIOXIDE; 37.5 g/450g CALCIUM SULFATE; 37.5 g/450g POTASSIUM PHOSPHATE
  • Administration Route(s): ORAL
  • Dosage Form(s): TABLET, CHEWABLE
  • Pharmacy Class(es): Blood Coagulation Factor [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: LDD Bioscience Private Limited
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/20/2026

Package Information

No. Package Code Package Description Billing Unit
187835-103-01450 g in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK (87835-103-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC87835-103The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEBio Combination 28The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMESchuessler SaltsThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, CHEWABLEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/20/2026This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMELDD Bioscience Private LimitedName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECALCIUM FLUORIDE; CALCIUM PHOSPHATE; FERROUS PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; MAGNESIUM PHOSPHATE; SODIUM CHLORIDE; SODIUM PHOSPHATE; SODIUM SULFATE; SILICON DIOXIDE; CALCIUM SULFATE; POTASSIUM PHOSPHATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH37.5; 37.5; 37.5; 37.5; 37.5; 37.5; 37.5; 37.5; 37.5; 37.5; 37.5; 37.5 
ACTIVE INGRED UNITg/450g; g/450g; g/450g; g/450g; g/450g; g/450g; g/450g; g/450g; g/450g; g/450g; g/450g; g/450g 
PHARM CLASSESBlood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 9/11/2026

Previous Code
Next Code